Literature DB >> 428147

Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

J van der Maulen, A A Wouda, E Mandema, T H The.   

Abstract

Phagocytosed immune complexes in polymorphonuclear (PMN) leucocytes of sixty-nine patients with Raynaud's phenomenon were studied by scoring the cells for IgG and complement inclusions. The results were compared with the degree of vasospasm, as measured by photoelectric plethysmography of the fingers after cooling. Median IgG and complement scores of PMN cells were significantly elevated in patients with Raynaud's phenomenon when compared with those of the control group (P less than 0.01). Patients with a positive (n = 35) or a strongly positive (n = 11) plethysmographic test showed significantly higher median IgG and complement scores than those with a negative plethysmorgraphic test (n = 23). They also showed elevated IgG and complement scores in a greater proportion (89 and 100%, respectively, vs 48%).Thus, a positive relationship was shown to exist between the degree of vasospasm and the levels of phagocytosed immune complexes in circulating PMN leucocytes. In secondary Raynaud's phenomenon high levels of phagocytosed immune complexes were found. In primary Raynaud's, patients with some clinical or laboratory signs of an auto-immune disease (n = 12), who were classified as "suspected secondary", had higher IgG and complement scores than those without such signs (n = 37). This suggests that the test for immune complex detection may distinguish patients with connective tissue disease-associated Raynaud's phenomenon from those with truly primary Raynaud's, in an early stage of the disease. The clinical and patho-physiological implications of these findings with regard to the Raynaud phenomenon are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428147      PMCID: PMC1537581     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.

Authors:  A A Wouda
Journal:  Acta Med Scand       Date:  1977

2.  Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; H A Huiges; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

Review 3.  Immunologic tissue injury mediated by neutrophilic leukocytes.

Authors:  C G Cochrane
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 4.  The Raynaud syndrome.

Authors:  M Birnstingl
Journal:  Postgrad Med J       Date:  1971-05       Impact factor: 2.401

5.  Plasmapheresis in Raynaud's disease.

Authors:  G Talpos; M Horrocks; J M White; L T Cotton
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

6.  Immune complex detection by immunofluorescence on polymorphonuclear leucocytes.

Authors:  J W Steffelaar; F J Ten Kate; M Nap; A J Swaak; C B De Graaffreitsma; E H Van Elven; T M Feltkamp-Vroom
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

7.  Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

8.  Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients.

Authors:  T H The; M van der Giessen; H A Huiges; H Schraffordt Koops; I van Wingerden
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

9.  Immunological mechanisms in the pathogenesis of vinyl chloride disease.

Authors:  A M Ward; S Udnoon; J Watkins; A E Walker; C S Darke
Journal:  Br Med J       Date:  1976-04-17
  9 in total
  5 in total

1.  Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.

Authors:  R G Malia; M Greaves; L M Rowlands; A C Lawrence; A Hume; N R Rowell; J Moult; C M Holt; N Lindsey; P Hughes
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

2.  Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis.

Authors:  C M Holt; N Lindsey; J Moult; R G Malia; M Greaves; A Hume; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Immunomodulators interfere with angiopathy but not vasospasm after subarachnoid haemorrhage in rabbits.

Authors:  M Ryba; K Iwańska; M Walski; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

Authors:  C A Penning; J Cunningham; M A French; G Harrison; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.

Authors:  A Kahan; B Amor; C J Menkes
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.